⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Regeneron and Telix Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
Telix and Regeneron Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
Follicular Lymphoma Market Insight, Epidemiology, and Forecasts, 2022-2026 & 2026-2036
globenewswire.com
AZN
GILD
ABBV
REGN
BIIB
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
globenewswire.com
SNY
REGN
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
globenewswire.com
REGN
SNY
7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments
globenewswire.com
ABBV
GSK
AZN
GILD
REGN
Powered Research at ARVO 2026
prnewswire.com
REGN
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month
globenewswire.com
AMGN
BMY
GSK
JNJ
REGN
SNY
PFE
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
globenewswire.com
KNSA
REGN